Search
for
Sort by
Research 271–300 of 1000+
- Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome
- Vertical and transverse sections of alopecia biopsy specimens: Combining the two to maximize diagnostic yield
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Efficacy and tolerability of methotrexate in severe childhood alopecia areata
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- A mixed methods survey of social anxiety, anxiety, depression and wig use in alopecia
- Sebaceous Gland Atrophy in Psoriasis: An Explanation for Psoriatic Alopecia?
- Neuroendocrine Perspectives in Alopecia Areata: Does Stress Play a Role?
- Alopecia areata − animal models
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Alopecia areata: An update
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Investigative guidelines for alopecia areata
- Prevalence and types of androgenetic alopecia in Shanghai, China: a community-based study
- Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild‐to‐moderate alopecia areata: A multicenter, prospective, randomized, controlled, investigator‐blinded trial
- Trichohyalin is a Potential Major Autoantigen in Human Alopecia Areata
- Primary cicatricial alopecia
- Twice Weekly 5 mg Dexamethasone Oral Pulse in the Treatment of Extensive Alopecia Areata
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- The Therapeutic Effect and the Changed Serum Zinc Level after Zinc Supplementation in Alopecia Areata Patients Who Had a Low Serum Zinc Level
- Generalized hair follicle hamartoma associated with alopecia and myasthenia gravis: report of a second case*
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States
- The Role of Micronutrients in Alopecia Areata: A Review
- JAK Inhibitors for Treatment of Alopecia Areata
- Factors Associated with Severity of Alopecia Areata
- The genetics of alopecia areata: New approaches, new findings, new treatments
- Oxidative Stress in Alopecia Areata: A Case–Control Study
- Sulfasalazine for alopecia areata
- Role of platelet-rich plasma in chronic alopecia areata: Our centre experience